DMAC: DiaMedica Therapeutics Inc. Stock

by  •  • Comments Off on DMAC: DiaMedica Therapeutics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 172.71
Enterprise Value ($M) 170.12
Book Value ($M) 33.95
Book Value / Share 0.79
Price / Book 5.09
NCAV ($M) 32.55
NCAV / Share 0.76
Price / NCAV 5.31

Profitability (mra)
Return on Invested Capital (ROIC) -0.79
Return on Assets (ROA) -0.55
Return on Equity (ROE) -0.58

Liquidity (mrq)
Quick Ratio 8.02
Current Ratio 8.02

Balance Sheet (mrq) ($M)
Current Assets 37.42
Assets 38.83
Liabilities 4.88
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -26.68
Net Income -24.44
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -22.08
Cash from Investing 8.56
Cash from Financing 11.99

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
07-08 13G Dialectic Capital Management, Lp 5.20

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-03-17 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-15 39,266 114,532 34.28
2025-05-14 93,853 204,927 45.80
2025-05-13 25,505 105,254 24.23
2025-05-12 23,639 114,625 20.62

(click for more detail)

Similar Companies
CYRX – Cryoport, Inc. DARE – Daré Bioscience, Inc.
DERM – Journey Medical Corporation DNTH – Dianthus Therapeutics, Inc.
DRMA – Dermata Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io